Changes of cytokine profiles during electroconvulsive therapy in patients with major depression

Journal of ECT

Volumn 29, Issue 3, 2013, Pages 162-169

  Rotter, Andrea ^a   Biermann, Teresa ^a   Stark, Christiane ^a   Decker, Anja ^b   Demling, Joachim ^a   Zimmermann, Rüdiger ^a   Sperling, Wolfgang ^a   Kornhuber, Johannes ^a   Henkel, Andreas ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b GfK Group   (Germany)

Author keywords

Cytokines; Depression; ECT

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; BONE MORPHOGENETIC PROTEIN 6; CYTOKINE; EOTAXIN 3; GRANULOCYTE COLONY STIMULATING FACTOR; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; LITHIUM; LYMPHOTOXIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE SEVERITY; DSM-IV; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; ICD-10; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PROTEIN EXPRESSION; PSYCHIATRIC DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; ANTIBODIES; CHEMOKINE CCL11; CYTOKINES; DATA INTERPRETATION, STATISTICAL; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEIZURES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883553517     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3182843942     Document Type: Article

References (51)

1. Sluzewska A, Rybakowski JK, Laciak M, et al. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci. 1995;762:474-476
2. Anisman H. Cascading effects of stressors and inflammatory immune system activation: Implications for major depressive disorder. J Psychiatry Neurosci. 2009;34:4-20
3. Song C, Wang H. Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:760-768
4. Feghali CA, Wright TM. Cytokines in acute and chronic inflammation. Front Biosci. 1997;2:d12Yd26
5. Maes M, et al. Immune disturbances during major depression: Upregulated expression of interleukin-2 receptors. Neuropsychobiology. 1990;24:115-120
6. Sutcigil L, Oktenli C, Musabak U, et al. Pro- and anti-inflammatory cytokine balance in major depression: Effect of sertraline therapy. Clin Dev Immunol. 2007;2007:76396
7. Naume B, Gately M, Espevik T. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. J Immunol. 1992;148:2429-2436
8. Bonnefoy JY, Denoroy MC, Guillot O, et al. Activation of normal human B cells through their antigen receptor induces membrane expression of IL-1 alpha and secretion of IL-1 beta. J Immunol. 1989;143:864-869
9. Lehtimaki K, Keränen T, Huuhka M, et al. Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder. J ECT. 2008;24:88-91
10. Hestad KA, Tønseth S, Støen CD, et al. Raised plasma levels of tumor necrosis factor alpha in patients with depression: Normalization during electroconvulsive therapy. J ECT. 2003;19:183-188
11. Zincke MT, Kurani A, Istafanous R, et al. The successful use of electroconvulsive therapy in a patient with interferon-induced psychotic depression. J ECT. 2007;23:291-292
12. Zhou Q, Desta T, Fenton M, et al. Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect Immun. 2005;73:935-943
13. Vargas DL, Nascimbene C, Krishnan C, et al. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57:67-81
14. Yin JL, Shackel NA, Zekry A, et al. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol. 2001;79:213-221
15. Vezzani A, Conti M, De Luigi A, et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: Functional evidence for enhancement of electrographic seizures. J Neurosci. 1999;19:5054-5065
16. Lehtimaki KA, Peltola J, Koskikallio E, et al. Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures. Brain Res Mol Brain Res. 2003;110:253-260
17. Sallmann S, Jüttler E, Prinz S, et al. Induction of interleukin-6 by depolarization of neurons. J Neurosci. 2000;20:8637-8642
18. Peltola J, Palmio J, Korhonen L, et al. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res. 2000;41:205-211
19. Lehtimaki KA, Keränen T, Huhtala H, et al. Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: The effect of seizure type and duration. J Neuroimmunol. 2004;152:121-125
20. Aharoni R, Teitelbaum D, Leitner O, et al. Specific TH2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1. Proc Natl Acad Sci U S A. 2000;97:11472-11477
21. Muller N, Schwarz M. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res. 2006;10:131-148
22. Maes M, Bosmans E, De Jongh R, et al. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1997;9:853-858
23. Lucas PC, McAllister-Lucas LM, Nunez G. NF-kappaB signaling in lymphocytes: A new cast of characters. J Cell Sci. 2004;117:31-39
24. Huang QJ, Jiang H, Hao XL, et al. Brain IL-1 beta was involved in reserpine-induced behavioral depression in rats. Acta Pharmacol Sin. 2004;25:293-296
25. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosom Med. 2009;71:171-186
26. Basterzi AD, Aydemir C, Kisa C, et al. IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol. 2005;20:473-476
27. Tuglu C, Kara SH, Caliyurt O, et al. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl). 2003;170:429-433
28. Murray PJ. The JAK-STAT signaling pathway: Input and output integration. J Immunol. 2007;178:2623-2629
29. Frommberger UH, Bauer J, Haselbauer P, et al. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: Comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci. 1997;247:228-233
30. Prather AA, Rabinovitz M, Pollock BG, et al. Cytokine-induced depression during IFN-alpha treatment: The role of IL-6 and sleep quality. Brain Behav Immun. 2009;23:1109-1116
31. Tonelli LH, Stiller J, Rujescu D, et al. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand. 2008;117:198-206
32. Timonen M, Jokelainen J, Hakko H, et al. Atopy and depression: Results from the Northern Finland 1966 Birth Cohort Study. Mol Psychiatry. 2003;8:738-744
33. Timonen M, Jokelainen J, Silvennoinen-Kassinen S, et al. Association between skin test diagnosed atopy and professionally diagnosed depression: A Northern Finland 1966 Birth Cohort study. Biol Psychiatry. 2002;52:349-355
34. Suzumura A, Sawada M, Itoh Y, et al. Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression. J Neuroimmunol. 1994;53:209-218
35. Yang MS, Ji KA, Jeon SB, et al. Interleukin-13 enhances cyclooxygenase-2 expression in activated rat brain microglia: Implications for death of activated microglia. J Immunol. 2006;177:1323-1329
36. Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry. 2011;16:751-762
37. Guloksuz S, Cetin EA, Cetin T, et al. Cytokine levels in euthymic bipolar patients. J Affect Disord. 2010;126:458-462
38. Hallberg L, Janelidze S, Engstrom G, et al. Exercise-induced release of cytokines in patients with major depressive disorder. J Affect Disord. 2010;126:262-267
39. Fischler B, Bocken R, Schneider I, et al. Immune changes induced by electroconvulsive therapy (ECT). Ann N Y Acad Sci. 1992;650:326-330
40. Kronfol Z, Nair MP, Weinberg V, et al. Acute effects of electroconvulsive therapy on lymphocyte natural killer cell activity in patients with major depression. J Affect Disord. 2002;71:211-215
41. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science. 1998;281:1305-1308
42. Brustolim D, Ribeiro-dos-Santos R, et al. A new chapter opens in anti-inflammatory treatments: The antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol. 2006;6:903-907
43. Corcoran C, Connor TJ, O'Keane V, et al. The effects of vagus nerve stimulation on pro- and anti-inflammatory cytokines in humans: A preliminary report. Neuroimmunomodulation. 2005;12:307-309
44. Kim TG, Kim HY, Lee SH, et al. Systemic lupus erythematosus with nephritis is strongly associated with the TNFB*2 homozygote in the Korean population. Hum Immunol. 1996;46:10-17
45. Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: An NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med. 1991;173:209-219
46. Schiffer RB, Caine ED. The interaction between depressive affective disorder and neuropsychological test performance in multiple sclerosis patients. J Neuropsychiatry Clin Neurosci. 1991;3:28-32
47. Jun TY, Pae CU, Chae JH, et al. Tumor necrosis factor-beta gene polymorphism may not be associated with major depressive disorder in the Korean population. Psychiatry Clin Neurosci. 2003;57:31-35
48. Myint AM, Leonard BE, Steinbusch HW, et al. Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord. 2005;88:167-173
49. Pae CU. Potential role of lymphotoxin-alpha (tumor necrosis factor-beta) in the development of schizophrenia. Med Hypotheses. 2007;68:1359-1362
50. Goertzel BN, Pennachin C, de Souza Coelho L, et al. Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome. Pharmacogenomics. 2006;7:475-483
51. Hoge EA, Brandstetter K, Moshier S, et al. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety. 2009;26:447-455